How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage
V Rass, R Helbok - Current opinion in critical care, 2021 - journals.lww.com
How to diagnose delayed cerebral ischaemia and symptomatic v... : Current Opinion in Critical
Care How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent …
Care How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent …
2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke …
AIM: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …
Therapies for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage
VA Shah, LF Gonzalez, JI Suarez - Neurocritical care, 2023 - Springer
Delayed cerebral ischemia (DCI) is one of the most important complications of subarachnoid
hemorrhage. Despite lack of prospective evidence, medical rescue interventions for DCI …
hemorrhage. Despite lack of prospective evidence, medical rescue interventions for DCI …
The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
B Balança, B Bouchier, T Ritzenthaler - Revue neurologique, 2022 - Elsevier
Aneurysmal subarachnoid hemorrhage (SAH) is a rare event affecting relatively young
patients therefore leading to a high social impact. The management of SAH follows a …
patients therefore leading to a high social impact. The management of SAH follows a …
Primary results of the Vesalio NeVa VS for the treatment of symptomatic cerebral vasospasm following aneurysm subarachnoid hemorrhage (VITAL) study
Background Cerebral vasospasm (CV) after aneurysmal subarachnoid hemorrhage (aSAH)
is linked to worse neurological outcomes. The NeVa VS is a novel cerebral dilation device …
is linked to worse neurological outcomes. The NeVa VS is a novel cerebral dilation device …
CT perfusion-guided administration of IV milrinone is associated with a reduction in delayed cerebral infarction after subarachnoid hemorrhage
V Szabo, S Baccialone, F Kucharczak, C Dargazanli… - Scientific Reports, 2024 - nature.com
Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (aSAH) is a
singular pathological entity necessitating early diagnostic approaches and both prophylactic …
singular pathological entity necessitating early diagnostic approaches and both prophylactic …
Continuous intraarterial nimodipine infusion for the treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a retrospective, single-center …
A Kramer, M Selbach, T Kerz, A Neulen… - Frontiers in …, 2022 - frontiersin.org
Background Delayed cerebral ischemia (DCI) occurs after aneurysmal subarachnoid
hemorrhage (aSAH). Continuous intraarterial nimodipine infusion (CIAN) is a promising …
hemorrhage (aSAH). Continuous intraarterial nimodipine infusion (CIAN) is a promising …
Three Pillars of Recovery After Aneurysmal Subarachnoid Hemorrhage: A Narrative Review
D Ryan, S Ikramuddin, S Alexander, C Buckley… - Translational Stroke …, 2024 - Springer
Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating neurologic disease with
high mortality and disability. There have been global improvements in survival, which has …
high mortality and disability. There have been global improvements in survival, which has …
Diagnosis and endovascular management of vasospasm after aneurysmal subarachnoid hemorrhage—survey of real-life practices
Background Vasospasm and delayed cerebral ischemia (DCI) are the leading causes of
morbidity and mortality after intracranial aneurysmal subarachnoid hemorrhage (aSAH) …
morbidity and mortality after intracranial aneurysmal subarachnoid hemorrhage (aSAH) …
[HTML][HTML] Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018–2021: an overview of the current care situation
A Neumann, W Weber, J Küchler… - RöFo-Fortschritte auf …, 2023 - thieme-connect.com
Ziel Auswertung der 2018–2021 im DeGIR-Register dokumentierten endovaskulären
Therapien von zerebralen Vasospasmen (ZVS) zur Analyse der aktuellen klinischen …
Therapien von zerebralen Vasospasmen (ZVS) zur Analyse der aktuellen klinischen …